Canadian MedTechAlliance
Resources & FAQ
With the CAMEDA program, you receive funding to work with some of Canada’s leading Contract Development and Manufacturing Organizations (CDMOs) to help you advance regulatory approvals, conduct clinical trials, and undertake initial batch manufacturing. We’ve brought in key partners with specialized expertise in the medtech and medical device space – supporting you at a critical phase of your commercialization journey.
Frequently Asked Questions
- With an investment from the Government of Canada through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario), Innovation Factory, in collaboration with leading Canadian medical device contract development and manufacturing organizations (CDMOs), established the Canadian MedTechAlliance (CAMEDA) program. Its primary mission is to accelerate the manufacturing of innovative medical device technologies developed by life science firms across Ontario.
- Through CAMEDA, Ontario life science firms can work with world-class contract CDMOs, including Avania, Cortex Design, Engineering CPR, Inertia Product Development, Linamar, MegaLab Group, McMaster Manufacturing Research Institute and Microart Services. Successful partnerships will accelerate manufacturing and regulatory approval efforts, enabling life science firms to establish manufacturing capacity here in Canada. Successful CAMEDA applicants can access up to $100,000 in non-dilutive funding to support their work with a CAMEDA partner.
- Privately incorporated Canadian life science firms, with operations based primarily in Ontario that are at the final stages of regulatory approval and/or are ready to begin initial manufacturing of an innovative medical device.
- Eligible firms must be able to demonstrate commitment to commercializing their innovation with a clear clinical application.
- Applicants must be a member of Innovation Factory to be considered, signing up is free and can be done here.
- If your firm is primarily located outside of Ontario and you are interested in working with a CAMEDA partner, please contact the CAMEDA Program team, to explore potential options.
- All applicants must be matched with a CAMEDA delivery partner before being considered for a program grant.
- If the applying company has not previously identified and established a CAMEDA contract development and manufacturing organization (CDMO), then the CAMEDA program team will attempt to match high-potential applicants with one based on proposed scope of work.
- The CAMEDA program team does not guarantee that a match will occur, as it depends on the strategic alignment of all parties and their availability.
Eligible costs that can be included in the CAMEDA project budget are:
- Directly related to the intent of the CAMEDA Project.
- Defined as reasonable costs for items that directly support the objectives and activities of the approved CAMEDA Project.
- Incremental to the usual cost of doing business.
- Applications are open as of April 2024 and will close Fall 2027 – or if all funding has been allocated. We welcome submissions continuously, as applications are reviewed on a rolling basis.
- A member of the CAMEDA program team will review your application within 1-2 weeks before scheduling an introduction meeting to explore project suitability, alignment with CAMEDA program goals, and steps required to identify a suitable principal investigator/clinical champion.
- Work with the lead from the interested contract development and manufacturing organization (CDMO) to define the desired scope of CAMEDA Project activities.
- Sign the CAMEDA Project contract with Innovation Factory and the CDMO partner. The contract will outline the project scope, budget, critical activities, project milestones, and the expected business impact of the Commercialization Project.
- Start the CAMEDA Project.
- Funding will be released in tranches on a reimbursement basis.
- Once a firm has been successfully matched with a CAMEDA contract development and manufacturing (CDMO) partner and has submitted their project proposal, their complete application will be reviewed by the CAMEDA program team.
- A recommendation to support or deny the application will be made and comments will be provided back to the applying life science firm. The CAMEDA team will discuss submitted project proposals and make selection decisions within 1-2 weeks, recognizing the importance of a timely response.
- The CAMEDA team will do its best to notify firms that are not successful.
- Once recommended to receive CAMEDA funding, an approval letter will be sent to the applying life science firm and CAMEDA contract development and manufacturing organization (CDMO) partner notifying them of the success of their project proposal.
- This letter will trigger all parties to begin drafting the CAMEDA Project contract that defines all responsibilities and requirements required for the success of the project including the statement of work and project outcomes and goals.
- A CAMEDA Project contract template has been developed in consultation with the partner organizations. This template will be used to help expedite the contracting process. Please contact your partner organization once your project proposal has been reviewed and approved for funding.
- A secondary objective of CAMEDA is to enable new intellectual property (IP) to be created for the benefit of the life science firm. Unless otherwise agreed, ownership of any IP and/or trade secrets created as a result of the CAMEDA Project is assumed to vest wholly with the for-profit firm (“Foreground IP”).
- The CAMEDA Project contract will spell out explicitly how Foreground IP will be treated. Innovation Factory, Synapse Consortium and FedDev Ontario will not take any ownership stake in any IP generated as a result of a CAMEDA Project.
- In some cases, all parties involved may decide that joint ownership, or some other arrangement, may better reflect the interests of all parties involved. In this case, additional considerations of the treatment of Foreground IP will be explicitly articulated in the CAMEDA Project contract, whether through revenue sharing, licensing agreements, or some other means.
- It is understood that participating firms own all IP they bring to the CAMEDA Project with (“Background IP”). All parties are expected to adhere to Innovation Factory’s IP policy, as well as the IP policy of the CDMO partner.
Are you ready?
Apply Now
We encourage you to verify your eligibility and start your application journey. We welcome submissions continuously, as applications are reviewed on a rolling basis. Please note that the review process for project grants may take longer than usual.
Need more information?
Contact Us
If you have any questions regarding CAMEDA, please get in touch with us through our Contact form.
